FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Paratek Pharmaceuticals (PRTK) to Resume Trading at 2:50 pm ET
August 8, 2018 2:26 PM EDTParatek Pharmaceuticals (NASDAQ: PRTK) to Resume Trading at 2:50 pm ET
